Home | Repositories | Statistics | About



Subject: breast carcinoma
Subject: Her2/neu
Subject: Ki-67
Subject: p53
Subject: immunohistochemistry
Subject: prognostic factors


Year: 2002


Type: Proceeding article



Title: HER2/neu expression in correlation with p53 and Ki-67 immunoreactivity and clinicopathological parameters in breast cancer patients.


Author: Yashar, Genghis
Author: Basheska, Neli
Author: Ivkovski, Ljube
Author: Kraleva, Slavica
Author: Prodanova, Irina
Author: Vasev, Nikola
Author: Kubelka-Sabit, Katerina
Author: Smichkoska, Snezhana
Author: Zografski, George



Abstract: Introduction: Although the role of HER2/neu status is still unsettled, its determination is valuable in selecting breast carcinoma patients for adequate Herceptin therapy. Aims: The purpose of this study was to evaluate the association among HER2/neu, p53 and Ki-67 immunoreactivity, as well as clinicopathological parameters (tumour size, histopathologic grade, nuclear grade, tumour type. lymph-node status and age) in breast cancer patients. Materials and methods: HER2/neu, p53 and Ki-67 expression was determined in 169 post-operative stage I-III (UICC. 1997) breast cancer patients using the standardized DAKO HercepsTest and by immunoperoxidase technique. respectively. The results were evaluated by performing the standardized scoring system. Discussion and conclusion: HER2/neu expression was positive in 66 patients (37%). There was no association between HER2/neu expression and p53 or Ki-67 immunoreactivity as well as any clinicopathological parameter, while the values of Ki-67 and p53 were strongly interrelated (P < 0.001). Ki-67 was also in significant correlation to tumour size, lymph-node involvement and tumour type (P<0.001), while p53 was only related to patients' age (P <0.01). These results indicate that HER2/neu is an independent prognostic marker in differentiating a subgroup of high-risk breast cancer patients. Additional studies are required to adjust HER2/neu testing results to clinical outcome.


Publisher: Blackwell Publishing


Relation: Histopathology



Identifier: oai:repository.ukim.mk:20.500.12188/25062
Identifier: http://hdl.handle.net/20.500.12188/25062
Identifier: 10.1046/j.1365-2559.41.s1.2.x



TitleDateViews
HER2/neu expression in correlation with p53 and Ki-67 immunoreactivity and clinicopathological parameters in breast cancer patients.200220